GlassScriptPhysician profile
Mandy B Grier
NPI 1235138355
$1,404.25
in general payments reported to CMS, 2019-2025
22 companies · $249 in 2025
The $249 reported for 2025 was more than what 80% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $255 · 2020: $75.77 · 2021: $70.38 · 2022: $219 · 2023: $313 · 2024: $222 · 2025: $249.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $784.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $783.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tris Pharma INC | $184.96 | 2019-2025 | Dyanavel Xr |
| Ironshore Pharmaceuticals INC. | $184.17 | 2019-2024 | Jornay Pm |
| Corium, LLC | $167.58 | 2023-2025 | Azstarys |
| Merck Sharp & Dohme LLC | $163.27 | 2020-2024 | Vaxelis, Vaxneuvance, Gardasil 9 |
| Pfizer INC. | $126.02 | 2019-2025 | |
| Sanofi Pasteur INC. | $113.90 | 2021-2025 | |
| Sobi, INC | $66.19 | 2019-2023 | |
| Supernus Pharmaceuticals, INC. | $59.16 | 2023-2024 | Qelbree, Qelbree |
| Rhodes Pharmaceuticals L.P. | $44.61 | 2019 | |
| Neos Therapeutics, LP | $41.32 | 2020-2022 | |
| Glaxosmithkline, LLC. | $38.09 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $37.35 | 2023-2024 | Flumist Quadrivalent |
| Aytu Biopharma, INC. | $33.34 | 2023 | Karbinal |
| Cranial Technologies, INC | $18.67 | 2025 | Doc Band |
| Biogen, INC. | $18.62 | 2024 | Skyclarys |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kaleo, INC. | $17.79 | 2022 | |
| Sanofi-Aventis U.S. LLC | $17.00 | 2025 | |
| Vertical Pharmaceuticals, LLC | $16.85 | 2025 | Relexxii |
| Alexion Pharmaceuticals, INC. | $15.00 | 2019 | |
| Adlon Therapeutics L.P. | $13.51 | 2020 | |
| Seqirus USA INC | $13.44 | 2023 | Flucelvax Quadrivalent |
| Shire North American Group INC | $13.41 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mandy Grier listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.